A HALF-HOUR scan could nearly halve bladder cancer deaths, a study suggests. Giving patients an MRI scan before the usual ...
The BladderPath trial indicates that mpMRI can expedite MIBC treatment and improve bladder cancer-specific survival compared to traditional TURBT. The study showed a significant improvement in BCSS ...
Presentation of data at ESMO Congress 2025 shows MRI scanning before usual diagnostic route sped up time to treatment ...
Researchers in China combined findings from MRI scans with clinical features to create a new predictive model for nonmuscle-invasive bladder cancer recurrence.
Bladder cancer continues to pose a significant clinical challenge, with accurate imaging and treatment evaluation remaining pivotal in guiding patient management. Recent advances in imaging techniques ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...
The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...
Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.
Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback